Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "alexion pharmaceuticals"

Cowen and Company Reaffirms Buy Rating for Alexion Pharmaceuticals Inc. (ALXN)
Zolmax News

Calamos Advisors LLC Has $57,801,000 Stake in Alexion Pharmace...

Calamos Advisors LLC decreased its position in Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) by 6.5% during the second quarter, according to its most recent filing with the SEC. The fund owned 495,039 shares of the biopharmaceutical company's stock ... Zolmax News, 27 minutes ago
[x]  

90 images for alexion pharmaceuticals

American Banking News, 3 hours ago
Zolmax News, 14 hours ago
Octafinance, 1 day ago
Octafinance, 4 days ago
Octafinance, 1 week ago
Libya Business Info, 4 days ago
CIOReview, 5 days ago
Nasdaq, 1 week ago
Nasdaq, 2 weeks ago
Share Market Updates, 3 weeks ago
Libya Business Info

Alexion Employees Volunteer Together in Companys First Global Day of Service

NEW HAVEN, Conn.--( BUSINESS WIRE )-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that more than 1,500 employees around the world are volunteering in their respective communities as part of the Company's first Global Day of Service.
 Asian Hospital & Healthcare Management4 days ago ALEXION PHARMACEUTICALS : Employees Volunteer Together in Company's First Global Day of Service  4 Traders4 days ago Alexion Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Sept. 1, 2016)  Pharmacy Choice1 week ago European Commission Grants Orphan Drug Designation to ALXN1007 for the Treatment of Patients with Graft-Versus-Host Disease (GVHD)  PressReleasePoint1 week ago
[x]  

Alexion Pharmaceuticals' Rebound To Continue -Vetr Crowd

Shares of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) have lost 32.5 percent of their value since the beginning of the year. However, over the third quarter, the stock has recuperated more than 12.6 percent, and the Vetr crowd seems to believe the ...
 Benzinga.com1 month ago Don't Get Caught with These Stocks this Week According to Forcerank  Fat Pitch Financials2 weeks ago
[x]  
News.am

New drug costs $2mln for a one-year course

A new drug to treat a rare inherited bone disorder that was developed by Alexion Pharmaceuticals and could cost up to 1.5 million pounds ($2 million) a year per patient has been cleared for limited use by Britain's health cost watchdog. The ...
 News.am4 days ago UK okays Alexion drug costing up to $2 mln but wants price cut  Sharenet5 days ago UPDATE 1-UK okays Alexion drug costing up to $2 mln but wants price cut  Business Insider4 days ago Canadian company wades into U.S. drug price debate by offering to make cheaper cancer drug  HealthMediciNet.com3 weeks ago
[x]  
Nasdaq

Alexion Pharmaceuticals To Participate In Morgan Stanley Conference At 9:10 AM

. To access the live webcast, log on to http://ir.alexionpharm.com
 Nasdaq2 weeks ago
Freshnews.com

PACIFIC BIOSCIENCES OF CALIFORNIA : Biotech Stocks on Investors' Radar -- Alexion Pharma, BioMarin Pharma, Merrimack Pharma, and Pacific Biosciences of California

/PRNewswire/ -- Stock-Callers.com's focus shifted to Biotechnology industry which uses biological systems or living organisms for the development of biopharmaceutical drugs. Two main catalysts driving stocks in this arena are clinical and regulatory ...
 4 Traders3 weeks ago Biotech Stocks on Investors' Radar -- Alexion Pharma, BioMarin Pharma, Merrimack Pharma, and Pacific Biosciences of California  PR Newswire3 weeks ago Biotech Stocks on Investors Radar — Alexion Pharma, BioMarin Pharma, Merrimack Pharma, and...  Freshnews.com3 weeks ago
[x]  
Nasdaq

New Strong Sell Stocks for August 22nd

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: • Alexion Pharmaceuticals, Inc. ALXN develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in ...
 Yahoo! Singapore1 month ago
[x]  

Spiros Segalas on Alexion Pharmaceuticals

 Guru Focus1 month ago

Alexion Pharmaceuticals Becomes #49 Most Shorted Nasdaq 100 Component, Replacing Liberty Global

September 27, 2016 at 13:55 PM EDT Alexion Pharmaceuticals Becomes #49 Most Shorted Nasdaq 100 Component, Replacing Liberty Global The most recent short interest data has been released for the 09/15/2016 settlement date, and we here at ...
 Marketplace6 hours ago
[x]  

Johnson Controls International Now #164 Largest Company, Surpassing Alexion Pharmaceuticals

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Johnson Controls International plc (JCI) has taken over the #164 spot from Alexion Pharmaceuticals Inc. (ALXN), according to The
 Pettinga Financial Advisors1 day ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - alexion pharmaceuticals
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less